What Researchers Did
Researchers measured antioxidant enzyme levels in the red blood cells of multiple sclerosis patients and healthy controls, then observed how hyperbaric oxygen treatments affected these levels in MS patients.
What They Found
They found that multiple sclerosis patients had lower superoxide dismutase activity in their red blood cells compared to neurological controls. After hyperbaric oxygenation at 2 ATA with 100% oxygen, superoxide dismutase activity significantly increased in MS patients. Catalase activity also increased after exposure to both 10% and 100% oxygen at 2 ATA, while glutathione peroxidase activity remained unchanged.
What This Means for Canadian Patients
This study suggests that hyperbaric oxygen therapy might influence specific antioxidant enzymes in the red blood cells of multiple sclerosis patients. For Canadian patients, this research offers insights into how HBOT could potentially affect cellular processes in MS, though it does not provide direct treatment recommendations.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This study involved a small number of participants (18 patients) and focused solely on specific enzyme changes rather than clinical improvements.